The bill H. 3092 aims to amend the South Carolina Code of Laws by adding Section 44-41-95, which mandates the disclosure of specific medical information to women receiving a chemically induced abortion, particularly when mifepristone is administered. The bill outlines that physicians or individuals acting under their direction must provide a disclosure statement to the pregnant woman, which can be attached to the medication or prescription. The required disclosure informs the woman that mifepristone may not always be effective in terminating a pregnancy and encourages her to consult a healthcare provider if she regrets her decision.

Additionally, the bill clarifies that it does not create or recognize a right to abortion, nor does it require the disclosure statement to be given to women experiencing a spontaneous miscarriage. It also specifies that the responsibility for providing the disclosure lies solely with the facility administering the abortion, not with pharmacies or other entities. The act will take effect upon approval by the Governor, and it includes a provision ensuring that if any part of the act is deemed unconstitutional, the remaining sections will still remain valid.

Statutes affected:
12/05/2024: 44-41-95
Latest Version: 44-41-95
12/06/2024: 44-41-95